Skip Navigation

About Lawsuits

Suboxone Tooth Decay

Depo-Provera

Ozempic Wegovy and Mounjaro

Bard PowerPort

See if you qualify for compensation
See if you qualify for compensation

Dexcom Continuous Glucose Monitor Recall Issued Following Dozens of Injuries: FDA

Manufacturer is recalling devices after more than 50 injury reports related to speaker systems failing to alert users of dangerous blood sugar levels.

Dexcom Continuous Glucose Monitor Recall Issued Following Dozens of Injuries FDA
Darian Hauf

Add Your Comments

Federal health officials are warning that certain Dexcom glucose monitors may fail to sound alerts for dangerously high or low blood sugar levels, due to a potential defect.

The Dexcom continuous glucose monitor receiver recall was announced by the U.S. Food and Drug Administration (FDA) on July 17, after at least 56 injuries were linked to the issue.

Dexcom receivers are used at home or in healthcare settings, as part of a continuous glucose monitoring system, designed to track real-time glucose levels and alert users when intervention is needed.

However, officials warn that a speaker defect in some units may prevent the alarm from sounding, potentially resulting in serious health consequences, such as seizures, vomiting, loss of consciousness or death.

Do You Know about…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Do You Know About…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

While no deaths have been reported, the FDA has categorized this action as a Class I recall, the most severe type, indicating that continued use of the affected devices could result in life-threatening complications. 

The recall impacts the following Dexcom products with corresponding Unique Device Identifier (UDI) numbers:

  • G6 receivers, UDI: STK-FM-001, STK-FR-001
  • G7 receivers, UDI: STK-AT-011, STK-AT-012, ATK-AT-013, STK-GT-001, STK-GT-008, STK-GT-013, STK-GT-019, STK-GT-100, STK-GT-109, STK-GT-113
  • ONE receivers, UDI: STK-DO-006, STK-DO-013, STK-DO-103, STK-DO-109
  • ONE+ receivers, UDI: STK-D7-013, STK-D7-014, STK-D7-103

All impacted customers were sent an Urgent Medical Device Correction (PDF) on June 9, advising them to check their product inventory to determine if any devices are affected and, if so, to contact Dexcom for a free replacement.

Regardless of whether a receiver is affected, customers are advised to test the receiver’s speaker every time it is charged. Dexcom warns that even if the speaker beeps, it could still fail in the future without warning. The speaker can be re-tested at any time. If the speaker does not beep during testing, contact Dexcom immediately.

Customers with questions or who need a free replacement can contact Dexcom at 1-844-478-1600.

Health care professionals and other consumers may also report issues with the affected devices to the FDA’s safety information and adverse event reporting program, Medwatch.

Sign up to receive more safety recalls and other legal news that may affect you or your family.

Tags: blood sugar, continuous glucose monitor, Dexcom, Diabetes, glucose monitor, speaker malfunction
Written By: Darian Hauf

Consumer Safety & Recall News Writer

Darian Hauf is a consumer safety writer at AboutLawsuits.com, where she covers product recalls, public health alerts, and regulatory updates from agencies like the FDA and CPSC. She contributes research and reporting support on emerging safety concerns affecting households and consumers nationwide.

More Stories

0 Comments

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

High-Risk Brain Tumor From Depo-Provera Requires Frequent Monitoring, Lawsuit Claims
A Depo-Provera lawsuit indicates that a Washington state woman must receive ongoing medical monitoring and brain scans due to a high-risk brain tumor allegedly caused by the birth control shot.
Medtronic SCS Lawsuit Alleges Intellis LT Neurostimulator Caused Worsening Pain
An Illinois woman has joined a growing number of plaintiffs alleging that the Medtronic Intellis neurostimulator, and similar devices, may fail to relieve chronic pain and instead lead to worsening complications.
Court Outlines Plan To Prepare Suboxone Tooth Decay Lawsuits for Trial in Early 2028
Four Suboxone tooth decay lawsuits will eventually be selected and prepared for bellwether trials set to begin in March 2028, according to a court order.
Share:

About the writer

Darian Hauf

Darian Hauf

Darian Hauf is a consumer safety writer at AboutLawsuits.com, where she covers product recalls, public health alerts, and regulatory updates from agencies like the FDA and CPSC. She contributes research and reporting support on emerging safety concerns affecting households and consumers nationwide.